Dr. Jeffrey R. Jay, M.D.
@Great Point Partners Llc
Latest period2024 - Q3ReportedManaged Assets$339.762MTotal holdings29
Assets growth rate-34.91%Assets growth rate (2-Q avg)-26.77%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Great Point Partners Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 29 positions.
Assets under management
The assets under management (AUM) of Great Point Partners Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 339.762M in assets, with a quarterly growth rate of -34.91% and a 2-quarter average growth rate of -26.77%. The portfolio is managed by Dr. Jeffrey R. Jay, M.D., and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
VRDNViridian Therapeutics Inc
| 5.03% | $17.062M 750,000 shares@ $22.75 avg price | Increased 50% |
OLMAOlema Pharmaceuticals Inc
| 3.52% | $11.94M 1M shares@ $11.94 avg price | Increased 25.49% |
TCRXTscan Therapeutics Inc
| 1.49% | $5.062M 1.016M shares@ $4.99 avg price | Increased 8.03% |